For normalization, we gave a value of 1 1 to the densitometric CD1/actin data, obtained in cells transfected with the vacant vector

For normalization, we gave a value of 1 1 to the densitometric CD1/actin data, obtained in cells transfected with the vacant vector. milieu in multicellular organisms. Epithelial cells attach to each other by a group of intercellular contacts. At the uppermost portion of the lateral membrane, the paracellular space is usually sealed by tight junctions (TJs). This structure performs two crucial functions in epithelial cells: it both regulates the transit of ions and molecules via the intercellular space and maintains a polarized distribution of lipids and proteins between the apical and basolateral domains, by blocking their free diffusion within the plasma membrane. The TJ is usually constituted by transmembrane and adaptor proteins. Although the former establish cellcell contact through their extracellular domains, the latter work as scaffolds that reunite at a specific region of the membrane, a complex set of proteins that includes kinases, phosphatases, transcription factors (TFs), and small guanosine triphosphate-binding proteins, among others (for a review on TJ proteins, seeGonzalez-Mariscalet al., 2003). ZO-2 is usually a member of themembraneassociatedguanylatekinase homologous protein family (MAGUK) (Gumbineret al., 1991). All recognized family members include characteristic postsynaptic density 95/disc-large/zona occludens (PDZ), Src homology 3 (SH3) and guanylate kinase-like (GK) domains, all of them known to be involved in proteinprotein interactions (Gonzalez-Mariscalet al., 2000). Junctional proteins not only exert functions related to their barrier role at the plasma membrane but also are involved in transmission transduction, transferring information to the cell interior to modulate cell proliferation and differentiation (Baldaet al., 2003;Sourisseauet al., 2006). First evidence that this role may be attributed to ZO proteins was given from their high homology to the tumor suppressor protein DlgA (Willottet al., 1993;Woodset al., 1997). This notion has been further supported by the observation that in several carcinomas the expression of junctional proteins is usually down-regulated (for review, seeGonzalez-Mariscalet al., 2007) as shown for ZO-2 in breast and pancreatic malignancy (Chlenskiet al., 1999,2000). Furthermore, ZO-2 has been found to be a target for viral AZ7371 oncoproteins. Hence, the transforming potential of the adenovirus type 9 oncogenic determinant E4 (Ad9 E4-ORF1) is usually associated with its ability to bind and aberrantly sequester ZO-2 within the cytoplasm, whereas the AZ7371 overexpression of ZO-2 inhibits Ad9 E4-ORF1induced transformation (Glaunsingeret al., 2001;Latorreet al., 2005). The subcellular distribution of ZO-2 is usually responsive to the degree of cellcell contact. Thus in confluent epithelial monolayers, ZO-2 localizes at the TJ, whereas in sparse cultures characterized for their high proliferative state, a significant amount of ZO-2 concentrates in the nucleus (Islaset al., 2002). There, ZO-2 associates to the nuclear matrix (Jaramilloet al., 2004), displays a speckled distribution, Mouse monoclonal to HSP60 and colocalizes with the essential splicing factor SC-35 (Islaset al., 2002), and with the nuclear scaffold attachment factor SAF-B (Trawegeret al., 2003), a corepressor of estrogen receptor- known to regulate the transcription of genes involved in proliferation, apoptosis, and migration. For its movement in and out of the nucleus, four nuclear localization and five export signals have been recognized previously (Islaset al., 2002;Jaramilloet al., 2004;Gonzalez-Mariscalet al., 2006). In a previous work, we exhibited the specific conversation AZ7371 of ZO-2 with Jun and Fos TFs, which form a transcription complex named AP-1 (Betanzoset al., 2004). Because AP-1 is usually involved in cell proliferation, transformation, and death (Shaulian AZ7371 and Karin, 2002), we explored the impact of ZO-2 expression on the activity of the CD1 promoter, and observed that ZO-2 down-regulates CD1 transcription by interacting with the c-Myc/E box element and by recruiting histone deacetylases (Huertaet al., 2007). CD1 is usually rate limiting and essential for cell progression through the G1 phase of the cell cycle. CD1 binds to and activates the cyclin-dependent kinases Cdk4 and Cdk6, which in turn phosphorylate their downstream target the retinoblastoma protein (Rb). The latter binds to and negatively regulates the activities of E2F TFs. On Rb-dependent.